WT1 peptide vaccination combined with BCG-CWS is more efficient for tumor eradication than WT1 peptide vaccination alone

Author： Nakajima Hiroko   Kawasaki Kotomi   Oka Yoshihiro   Tsuboi Akihiro   Kawakami Manabu   Ikegame Kazuhiro   Hoshida Yoshihiko   Fujiki Fumihiro   Nakano Akiko   Masuda Tomoki   Wu Fei   Taniguchi Yuki   Yoshihara Satoshi   Elisseeva Olga   Oji Yusuke   Ogawa Hiroyasu   Azuma Ichiro   Kawase Ichiro   Aozasa Katsuyuki   Sugiyama Haruo  

Publisher： Springer Publishing Company

ISSN： 0340-7004

Source： Cancer Immunology, Immunotherapy, Vol.53, Iss.7, 2004-07, pp. : 617-624

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

WT1 peptide vaccination in a CML patient: induction of effective cytotoxic T lymphocytes and significance of peptide administration interval

By Saitoh Anri  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 219-230

Humana Press, Inc

Access to resources Recommend Favorite

WT1 Peptide Vaccine as a Paradigm for “Cancer Antigen-Derived Peptide”-Based Immunotherapy for Malignancies: Successful Induction of Anti-Cancer Effect by Vaccination with a Single Kind of WT1 Peptide

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 7, 2009-09 ,pp. : 787-797

Bentham Science Publishers

Access to resources Recommend Favorite

Phase I clinical trial of peptide vaccination with URLC10 and VEGFR1 epitope peptides in patients with advanced gastric cancer

By                  

International Journal of Oncology, Vol. 44, Iss. 3, 2014-01 ,pp. : 662-668

Spandidos Publications

Access to resources Recommend Favorite

Monitoring tumor antigen specific T-cell responses in cancer patients and phase I clinical trials of peptide-based vaccination

By Romero Pedro   Cerottini Jean-Charles   Speiser Daniel  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 3, 2004-03 ,pp. : 249-255

Springer Publishing Company

Access to resources Recommend Favorite

WT1, WTX and CTNNB1 mutation analysis in 43 patients with sporadic Wilms' tumor

By                      

Oncology Reports, Vol. 29, Iss. 1, 2013-01 ,pp. : 315-320

Spandidos Publications

Access to resources Recommend Favorite